Latest "irbesartan amlodipine irbesartan Hypertension" News Stories

17:58 EDT 30th September 2014 | BioPortfolio

Here are the most relevant search results for "irbesartan amlodipine irbesartan Hypertension" found in our extensive news archives from over 250 global news sources.

More Information about irbesartan amlodipine irbesartan Hypertension on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about irbesartan amlodipine irbesartan Hypertension for you to read. Along with our medical data and news we also list irbesartan amlodipine irbesartan Hypertension Clinical Trials, which are updated daily. BioPortfolio also has a large database of irbesartan amlodipine irbesartan Hypertension Companies for you to search.

Showing "irbesartan amlodipine irbesartan Hypertension" News Articles 1–25 of 1,000+

Extremely Relevant

Human medicines European public assessment report (EPAR): Irbesartan Zentiva (previously Irbesartan Winthrop), irbesartan, Revision: 14, Authorised

Human medicines European public assessment report (EPAR): Irbesartan Hydrochlorothiazide Zentiva (previously Irbesartan Hydrochlorothiazide Winthrop), irbesartan / hydrochlorothiazide, Revision: 18, Authorised

Human medicines European public assessment report (EPAR): Irbesartan Teva, irbesartan, Revision: 4, Authorised

Human medicines European public assessment report (EPAR): Irbesartan Teva, irbesartan, Revision: 5, Authorised

Human medicines European public assessment report (EPAR): Ifirmasta (previously Irbesartan Krka), irbesartan, Revision: 5, Authorised

Human medicines European public assessment report (EPAR): Irbesartan/Hydrochlorothiazide Teva, irbesartan / hydrochlorothiazide, Revision: 6, Authorised

Huahai Pharmaceutical Gets U.S. FDA Nod For Irbesartan Tablets

Huahai Pharmaceutical said it has won U.S. FDA approval for its generic irbesartan (Avapro) hydrochlorothiazide tablets under an Abbreviated New Drug Application to sell the products in the U.S. market.

Human medicines European public assessment report (EPAR): Sabervel, irbesartan, Revision: 1, Authorised

Human medicines European public assessment report (EPAR): Karvea, irbesartan, Revision: 30, Authorised

Human medicines European public assessment report (EPAR): Aprovel, irbesartan, Revision: 31, Authorised

Human medicines European public assessment report (EPAR): Sabervel, irbesartan, Revision: 2, Authorised

Human medicines European public assessment report (EPAR): CoAprovel, irbesartan / hydrochlorothiazide, Revision: 29, Authorised

Human medicines European public assessment report (EPAR): Karvezide, irbesartan / hydrochlorothiazide, Revision: 30, Authorised

Human medicines European public assessment report (EPAR): Ifirmacombi, irbesartan / hydrochlorothiazide, Revision: 2, Authorised

Relevant

Simultaneous Determination of Amlodipine and Its Counterion Besylate

Thermo Fisher Scientific has developed a simple, rapid, reliable, and accurate high-performance liquid chromatography (HPLC) method for the simultaneous determination of amlodipine and besylate in an amlodipine besylate drug substance. Application Note 1087: Simultaneous Determination of Amlodipine and Its Counterion Besylate by HPLC demonstrates that this method requires only ...

Par Pharmaceutical Begins Shipment of Generic Exforge®

WOODCLIFF LAKE, N.J., Sept. 30, 2014 /PRNewswire/ -- Par Pharmaceutical Companies, Inc. today announced that it has begun shipping all four strengths of amlodipine and valsartan tablets, the generic version of Novartis' Exforge®.  Par received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for amlodipine and valsartan and was grant...

Efficacy of olmesartan/amlodipine combination therapy in reducing ambulatory blood pressure in moderate-to-severe hypertensive patients not controlled by amlodipine alone

FDA accepts Symplmed's Prestalia NDA for hypertension treatment

Symplmed announced today that the U.S. Food and Drug Administration has accepted for review its New Drug Application (NDA) for investigational drug Prestalia, the first single-pill, fixed-dose combination (FDC) of perindopril arginine and amlodipine ...

Zacras® Combination Tablets LD and Zacras® Combination Tablets HD, Fixed-Dose Combination of Azilsartan and Amlodipine, and Azilva® Tablets 10mg, Treatment for Hypertension, are Now Available in Japan

News Release

Transfer of Distribution and Termination of Co-promotion for Caduet® Combination Tablets

Pfizer Japan Inc. (Tokyo, “Pfizer”) and Astellas Pharma Inc. (Tokyo: 4503, “Astellas”) today announced that the companies have agreed to terminate the distribution and co-promotion agreement in Japan for a combination drug o...

Par Pharmaceutical starts shipping generic version of Exforge

Par Pharmaceutical Companies, Inc. today announced that it has begun shipping all four strengths of amlodipine and valsartan tablets, the generic version of Novartis' Exforge. Par received final approval from the U.S. Food and Drug Administration for...

Udenafil vs Amlodipine in Secondary Raynaud's Phenomenon

Is udenafil or amlodipine more effective in the treatment of secondary Raynaud's phenomenon? Rheumatology

Which New Hypertension Guidelines Are the Best?

Three separate hypertension guidelines were released last year. Speakers at HYPERTENSION 2014 were tasked with convincing the audience which set of recommendations is the best. Heartwire

Resistant Hypertension or Noncompliance? A Push for Answers

Hypertension doctors gathering here are turning with renewed attention to the questions: how many patients truly have "resistant" hypertension, and what's the best way to get blood pressure down? Heartwire

Hypertension: Fluid overload and post-dialysis hypertension

Although intradialytic hypertension is associated with all-cause mortality, the mechanisms that underlie this phenomenon are not well understood. Now, Nongnuch et al. report that post-dialysis hypertension is associated with extracellular fluid over...


Search BioPortfolio:
Loading
Advertisement
Advertisement

News Quicklinks